Loading...
XJPX
6960
Market cap1.91bUSD
Jul 10, Last price  
11,230.00JPY
1D
-2.35%
1Q
5.94%
Jan 2017
248.22%
Name

Fukuda Denshi Co Ltd

Chart & Performance

D1W1MN
XJPX:6960 chart
P/E
16.15
P/S
2.17
EPS
695.52
Div Yield, %
1.74%
Shrs. gr., 5y
-1.88%
Rev. gr., 5y
-0.98%
Revenues
139.70b
+0.50%
88,270,000,00088,568,000,00089,551,000,00088,147,000,00090,169,000,00092,524,000,00096,239,000,000107,574,000,000108,269,000,000117,222,000,000121,747,000,000128,883,000,000129,775,000,000133,393,000,000146,756,000,000132,098,000,000134,648,000,000140,323,000,000139,007,000,000139,697,000,000
Net income
18.79b
+0.99%
3,353,000,0003,174,000,0003,770,000,0003,498,000,0004,111,000,0005,266,000,0006,462,000,0007,540,000,0007,119,000,0007,368,000,0008,776,000,0009,320,000,0009,577,000,0009,609,000,00014,716,000,00016,216,000,00017,278,000,00018,693,000,00018,605,000,00018,790,000,000
CFO
29.33b
-11.18%
8,298,000,0005,855,000,00014,663,000,00012,195,000,00013,760,000,0008,513,000,00012,199,000,00011,115,000,00012,851,000,00011,758,000,00015,693,000,00018,073,000,00014,006,000,00020,365,000,00021,801,000,00023,282,000,00023,137,000,00023,914,000,00033,019,000,00029,328,000,000
Dividend
Sep 30, 2026115 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Fukuda Denshi Co., Ltd. manufactures and supplies medical devices to both Japanese and international clients. Their offerings span a range of products, including resting electrocardiography equipment, data management software, and stress test apparatus. Additionally, they provide comprehensive patient monitoring systems, such as central and bedside monitors, transmitters, and central viewer workstations, as well as vascular screening solutions. The company, headquartered in Tokyo, Japan, was established in 1939.
URL
https://www.fukuda.co.jp/
IPO date
Jun 01, 1982
Employees
3,382
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT